applied therapeutics inc shares fell 33 to 72 cents in afterhours trading wednesday after the company said it plans to make a public offering of its common stock and warrants the clinicalstage biopharmaceutical company said proceeds from the offering for shares of its common stock prefunded warrants to purchase common stock in lieu of common stock to certain investors and accompanying warrants to purchase shares of its common stock are intended for general corporate purposes such as research and development costs as well as capital expenditures among other purposes